Lisata Therapeutics

(NASDAQ) CLBS

Current PriceN/A

Market CapN/A

Since IPO (1991)-100%

5 Year-86%

1 Year+42%

1 Month-35%

Lisata Therapeutics Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$170.00K

Net Income (TTM)

$16.59M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

CLBS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lisata Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David J. Mazzo, PhD

Website

www.lisata.com

Headquarters

Basking Ridge, NJ 07920, US

CLBS Financials

Key Financial Metrics (TTM)

Gross Margin

91%

Operating Margin

-107%

Net Income Margin

-98%

Return on Equity

-84%

Return on Capital

-1%

Return on Assets

-93%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

$0.00

EBITDA

$0.00

Operating Cash Flow

$15.95M

Capital Expenditure

$28.00K

Free Cash Flow

$15.98M

Cash & ST Invst.

$15.96M

Total Debt

$0.00

Lisata Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$100.00K

+100.1%

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$2.95M

-26.3%

EBITDA

$4.21M

+292.2%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$15.96M

-48.9%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-93.47%

N/A

Return on Invested Capital

-1.24%

N/A

Free Cash Flow

$3.25M

+13.4%

Operating Cash Flow

$3.25M

+19.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ONCOOnconetix, Inc.

ONCOOnconetix, Inc.$0.40-10.22%

IDRAIdera Pharmaceuticals, Inc.

IDRAIdera Pharmaceuticals, Inc.$0.42-23.04%

VIVSVivoSim Labs, Inc.

VIVSVivoSim Labs, Inc.$1.41+0.00%

QTTBQ32 Bio Inc.

QTTBQ32 Bio Inc.$5.37-1.90%

ARAVAravive, Inc.

ARAVAravive, Inc.$0.04-13.39%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.47+0.07%

INTCIntel

INTCIntel$109.62-0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.34-0.00%

SNAPSnap

SNAPSnap$5.98-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.18+0.02%

ATRAAtara Biotherapeutics

ATRAAtara Biotherapeutics$9.93+0.93%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$45.73+0.00%

Questions About CLBS

What is the current price of Lisata Therapeutics?

Lisata Therapeutics is trading at N/A per share.

What is the 52-week range for Lisata Therapeutics?

Over the past 52 weeks, Lisata Therapeutics has traded between N/A and N/A.

How much debt does Lisata Therapeutics have?

As of the most recent reporting period, Lisata Therapeutics reported total debt of N/A.

How much cash does Lisata Therapeutics have on hand?

Lisata Therapeutics reported $15.96M in cash and cash equivalents in its most recent financial results.

What is Lisata Therapeutics’s dividend yield?

Lisata Therapeutics does not currently have a dividend yield.

Lisata Therapeutics

Lisata Therapeutics Financials at a Glance

CLBS News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Lisata Therapeutics

CLBS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Lisata Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CLBS

What is the current price of Lisata Therapeutics?

What is the 52-week range for Lisata Therapeutics?

How much debt does Lisata Therapeutics have?

How much cash does Lisata Therapeutics have on hand?

What is Lisata Therapeutics’s dividend yield?

Premium Investing Services